ArticleOpen life sciences2020

Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma.

Dan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.